Akuos Inc.
Gene therapy for hereditary hearing loss
📊
$6M
Annual Revenue
👥
40
Employees
📦
2
Products
45%
45%
Profile Completeness
📄 About Akuos Inc.
Akuos develops adeno-associated virus gene therapy products for the treatment of hereditary and acquired sensorineural hearing loss delivered via cochlear infusion.
🛡️
High Quality
Products
Products
🌐
Global
Distribution
Distribution
💡
Innovative
Technology
Technology
👥
Customer
Focused
Focused
📦 Featured Products
View All Products →
No products currently listed for Akuos Inc..
📍 Location & Offices
View on Map
🗺️
New Haven, USA
📋 Request a Quote
Send your requirements directly to Akuos Inc.. Response typically within 48 hours.
